Pfizer: COVID vaccine 100% effective in children aged 12-15

Wednesday, 31. March 2021 12:49

Pfizer announced on Wednesday that its coronavirus vaccine co-developed with BioNTech is 100% effective in kids between the ages of 12 and 15 following a phase three clinical trial.

"We share the urgency to expand the authorization of our vaccine to use in younger populations and are encouraged by the clinical trial data from adolescents between the ages of 12 and 15," Pfizer Chairman and Chief Executive Officer Albert Bourla said in a statement. He added that Pfizer would submit the fresh data to the Food and Drug Administration in the coming weeks.

Pfizer's trial enrolled 2,260 adolescent participants in the United States.

Related Links: Pfizer Inc.
Breaking the News / JC